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Abstract
Coronary artery disease, heart failure, fatal arrhythmias, stroke, and renal disease are the most common causes of
mortality for humans, and essential hypertension remains a major risk factor. Elucidation of susceptibility loci for
essential hypertension has been difficult because of its complex, multifactorial nature involving genetic,
environmental, and sex- and age-dependent nature. We investigated whether the 11p15.5 region syntenic to rat
chromosome 1 region containing multiple blood pressure quantitative trait loci (QTL) detected in Dahl rat intercrosses
harbors polymorphisms that contribute to susceptibility/resistance to essential hypertension in a Sardinian population.
Initial testing performed using microsatellite markers spanning 18 Mb of 11p15.5 detected a strong association
between D11S1318 (at 2.1 Mb, P = 0.004) and D11S1346 (at 10.6 Mb, P = 0.00000004), suggesting that loci in close
proximity to these markers may contribute to susceptibility in our Sardinian cohort. NLR family, pyrin domain
containing 6/angiotensin-vasopressin receptor (NLRP6/AVR), and adrenomedullin (ADM) are in close proximity to
D11S1318 and D11S1346, respectively; thus we tested single nucleotide polymorphisms (SNPs) within NLRP6/AVR
and ADM for their association with hypertension in our Sardinian cohort. Upon sex stratification, we detected one
NLRP6/AVR SNP associated with decreased susceptibility to hypertension in males (rs7948797G, P = 0.029; OR =
0.73 [0.57–0.94]). For ADM, sex-specific analysis showed a significant association between rs4444073C, with
increased susceptibility to essential hypertension only in the male population (P = 0.006; OR = 1.44 [1.13–1.84]). Our
results revealed an association between NLRP6/AVR and ADM loci with male essential hypertension, suggesting the
existence of sex-specific NLRP6/AVR and ADM variants affecting male susceptibility to essential hypertension.
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Introduction
Essential hypertension is a highly prevalent disorder and
remains a major risk factor for the most common causes of
mortality, including coronary artery disease, heart failure, fatal
arrhythmias, stroke, and renal disease [1,2]. As a complex,
multifactorial disorder, elucidation of susceptibility loci remains
difficult. Previous studies have emphasized the challenges of
genetically analyzing essential hypertension [3-5]. Genome-
wide association studies have failed to detect major
hypertension susceptibility genes that may contribute greater
than 5 mmHg to the blood pressure (BP) effect [6-9]. These
studies reported that several loci were significantly associated
with increased BP by analyzing tens of thousands of patients in
a multi-center, meta-analysis paradigm with BP effects ranging
from 0.5–1 mmHg [6-9]. This implies that either hundreds of
hypertension susceptibility genes exist that account for
essential hypertension in humans, with each locus contributing
a small fraction of the increase in BP (0.5–1 mmHg effect), or
the studies have failed to detect major hypertension
susceptibility loci due to major confounders, such as inherent
genetic heterogeneity of human populations, great variability in
trait measurements, the existence of several factors that are
not accounted for, and factors in the analytical paradigm (e.g.,
sex-specific effects, gestational risk factors, and presence of
hypertension subtypes with unique pathogenetic mechanisms).
For complex multifactorial diseases with clinical
heterogeneity such as hypertension, genetic studies of inbred
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rat models of polygenic (essential) hypertension are
instrumental for identifying BP-quantitative trait loci (QTL) and
candidate susceptibility genes for subsequent testing in human
essential hypertension. We have successfully employed this
approach to identify ATP1A1 (α1 Na,K-ATPase) [10,11] and
DEspR (dual endothelin1/vascular endothelial growth factor
signal peptide receptor) [12,13] as candidate hypertension
genes in a Dahl salt-sensitive rat model of polygenic
hypertension. Subsequent studies detected an association of
ATP1A1 [14,15] and DEspR [15] with essential hypertension in
humans and revealed a functionally significant DEspR T/
CATAAAA-box promoter variant associated with 7.7 mmHg in
increased systolic BP in a male Sardinian population [16]. We
recently reported two closely-linked BP QTLs on
chromosome-1 (chr1) (BP-m1 at 144.3 Mb and BP-m2 at 208.8
Mb) affecting salt-sensitive hypertension in Dahl rats [12].
These two chr1-BP QTLs contain some candidate genes,
which has been supported by experimental evidence. Briefly,
molecular genetic evidence demonstrates that a functionally
significant N119S/C163R variant of the angiotensin-
vasopressin receptor (NLRP6/AVR at 201.08 Mb), which
exhibits sodium-induced dysfunction [17], may underlie chr1
BP-m1 QTL of salt-sensitive hypertension in F2 (Dahl S x Dahl
R]-intercross male rats [12]. Another candidate gene in this
chr1-BP QTL region includes adrenomedullin (ADM; at 168.38
Mb), which has been implicated in hypertension pathogenesis
[18,19] and may underlie BP-m2 QTL [12].
Analyses of BP-m1 and BP-m2 corresponding syntenic
regions in humans localized this chromosomal segment to the
11p15.5 region. We therefore investigated whether this
11p15.5 region harbors polymorphisms contributing to
susceptibility/resistance to essential hypertension in our
Sardinian population.
Results
Association between 11p15.1-11p15.5 region and
essential hypertension
To enhance robustness of the population under study, we
ascertained first a limited genetic diversity by restricting the
cohort under analysis to a relatively isolated genetic population
of northern Sardinia [20,21] and second , we minimized
subtype heterogeneity by focusing on the extreme of the
population to distinguish hypertensive patients and
normotensive controls. Thus, we compared ascertained
hypertensive patients (n = 433) with group means for systolic
BP (SBP) of 174.4 ± 14.7 mmHg and diastolic BP (DBP) of
110.5 ± 9.9 mmHg against control normotensives (n = 279)
with group means for SBP of 127.6 ± 11.3 mmHg and DBP of
77.6 ± 7.2 mmHg (Table 1). Both groups contained equivalent
representation of both sexes (Table 1).
Initial testing of possible loci associated with essential
hypertension within the 11p15.1–11p15.5 region was
performed with microsatellite markers spanning 18 Mb of this
chromosome 11 region. Since microsatellite markers are highly
variable, they typically reveal a significant amount of
information; therefore, they may be useful for examining large
genomic segments in linkage and/or association studies
[22,23]. As shown in Table 2, the D11S1318 and D11S1346
microsatellite markers showed a strong association with
hypertension susceptibility after adjusting for multiple testing
(D11S1318, P = 0.004; D11S1346, P = 0.00000004). This
suggests that loci in closed proximity to D11S1318 and
D11S1346 contribute to hypertension susceptibility in our
Sardinian cohort.
Single-point association analysis of NLRP6/AVR and
ADM loci
Closed examination of genes in the vicinity of D11S1318 and
D11S1346 identify NLRP6/AVR (at 278570) and ADM (at
10327248) as candidates for the corresponding associated
regions marked by D11S1318 and D11S1346, respectively
(Table 2). To assess the possible association of NLRP6/AVR
and ADM with essential hypertension in our Sardinian cohort,
we examined single-point associations between NLRP6/AVR
and ADM SNPs (Figure 1, Table 3) with hypertension
susceptibility. We used 4 tagged SNPs for the NLRP6/AVR
Table 1. Characteristics of the study population.
Variable NTa (total) HTb (total) Male NT Female NTMale HT Female HT
n 279 433 131 148 237 196














































10.4 108.8 ± 9.0
a Normotensives; b hypertensives; total, male + female subjects; c years; d body
mass index; e kilogram per meter squared; f systolic blood pressure; g millimeters
mercury; h diastolic blood pressure.
doi: 10.1371/journal.pone.0077562.t001
Table 2. Association analysis of 11p15.1-11p15.5 region
with hypertension susceptibility.
Marker Position χ2 df P Pb Candidate (bp)
D11S1318 2327223 27.17 8 0.00066 0.0040 NLRP6/AVR(278570)
D11S1338 5987976 4.025 2 0.1337 0.8022  
D11S1323 6276714 2.914 3 0.4050 1.0000  
D11S1346 10959374 43.74 4 0.000000007 0.00000004 ADM (10327248)
D11S1315 12804576 1.508 4 0.8253 1.0000  
D11S1310 17622865 1.755 2 0.4158 1.0000  
NLRP6,NLR family, pyrin domain containing 6; AVR, angiotensin-vasopressin
receptor; ADM, adrenomedullin. df, degrees of freedom; P, nominal P values; Pb,
P values with the Bonferroni adjustment. Significant results after bonferroni
adjustment (P < 0.05) are shown in boldface type. Marker positions on
chromosome 11p15.1-11p15.5 region as per NCBI Human Annotation Release
104, GRCh37.p10-Primary Assembly.
doi: 10.1371/journal.pone.0077562.t002
AVR and ADM loci in Essential Hypertension
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 locus and 2 tagged SNPs for the ADM locus (see Materials
and Methods section). Genomic location, allele frequency, and
Hardy-Weinberg test results for the 6 tagged SNPs are
presented in Table 3. None of the tagged SNPs deviated
significantly from Hardy-Weinberg equilibrium in both
hypertensive and normotensive cohorts (Table 3). One of the
NLRP6/AVR SNPs, rs7937440, demonstrated a significant
association with hypertension in the total cohort after
adjustment for multiple testing (P = 0.032, Table 4). Upon sex
stratification, one NLRP6/AVR SNP (minor allele rs7948797G,
Table 4) was associated with decreased susceptibility to
hypertension only in the male population (P = 0.029; OR = 0.63
[0.45–0.88], Table 4). For ADM, sex-specific analysis detected
a significant association between rs4444073C minor allele and
increased susceptibility to hypertension exclusively in the male
cohort as well (P = 0.013; OR = 1.62 [1.14–2.29], Table 4).
Discussion
Identifying genes underlying susceptibility to essential
hypertension has been difficult. Genome-wide association
studies have failed to detect significant associations
contributing greater than 5 mmHg in blood pressure despite the
large number of subjects examined in different studied cohorts
[6-9]. A number of reasons may account for these negative
findings, including intrinsic genetic heterogeneity of human
populations, differential accuracy and/or modality in trait
measurements (blood pressure), exclusion of putative sex-
specific effects on the phenotype in the analytical paradigm,
and gestational risk factors.
Table 3. Description of the tagged SNPs genotyped.
Gene (chr), SNP A/R Position MAF P (NT) P (HT)
NLRP6/AVR (11)      
rs7948797 A/G 269856 0.295 0.603 0.528
rs7937440 A/G 272199 0.417 0.601 0.636
rs11246048 T/C 278039 0.365 0.533 0.238
rs4758635 G/T 283928 0.470 0.438 0.956
ADM (11)      
rs4399321 A/G 10323478 0.280 0.239 0.148
rs4444073 A/C 10331664 0.344 0.988 0.572
NLRP6, NLR family, pyrin domain containing 6; AVR, angiotensin-vasopressin
receptor; ADM, adrenomedullin; A/R, ancestral allele/rare allele; MAF, minor allele
frequency; P (NT), Hardy-Weinberg P value in normotensives; P (HT), Hardy-
Weinberg P value in hypertensives. SNP locations as per NCBI Human Annotation
Release 104, GRCh37.p10-Primary Assembly.
doi: 10.1371/journal.pone.0077562.t003
Figure 1.  Structure of NLRP6/AVR and ADM genes and location of the SNPs analyzed.  Exons (shown as boxes) 1–8 for
NLRP6/AVR and exons 1–4 for ADM are shown. Gene untranslated (5′-untranslated and 3′-untranslated) regions are unfilled.
Corresponding nucleotide positions for the NLRP6/AVR and ADM loci on chromosome 11 are indicated in bp. Locations of the
SNPs genotyped are shown by vertical lines.
doi: 10.1371/journal.pone.0077562.g001
AVR and ADM loci in Essential Hypertension
PLOS ONE | www.plosone.org 3 October 2013 | Volume 8 | Issue 10 | e77562
Here, we present evidence suggesting that the NLRP6/AVR
and ADM loci contribute to hypertension susceptibility in a
Sardinian population. We first detected strong association of
the 11p15.1–11p15.5 region with hypertension showing two
distinct peaks marked by D11S1318 and D11S1346 SSLP
markers. Their chromosomal location indicated NLRP6/AVR
and ADM as putative loci underlying the observed associations.
Subsequent analysis using SNPs spanning both the
NLRP6/AVR and ADM transcription units confirmed their
associations with essential hypertension in our Sardinian
cohort. Both loci demonstrated sex-specific effects on
hypertension susceptibility and were primarily associated with
male essential hypertension.
ADM is a potent vasodilatory peptide important for blood
pressure homeostasis, as well as cardiovascular and renal
function [18,24,25]. Its role in blood pressure regulation has
been substantiated by showing that heterozygous ADM+/-
knockout male mice exhibited elevated blood pressure when
compared with wild-type littermates [26]. The ADM locus has
been detected as a genome-wide significant finding in a
recently reported study involving a large population [8]. In
addition, the ADM SNP rs4399321 utilized in our study has
been reported to be associated with proteinuria in subjects with
essential hypertension [27] and with BP levels in normotensive
subjects in a Chinese population [28] supporting a regulatory
role for ADM in blood pressure homeostasis in humans.
Moreover, recent studies have implicated ADM in hypertension
pathogenesis in humans. A dose-response relationship
between ADM and BP status was observed among age- and
sex-matched normotensive, pre-hypertensive, and
hypertensive subjects, detecting lower ADM levels in the
hypertensive group than in the pre-hypertensive and
normotensive groups [19]. Moreover, ADM levels were found to
be associated with mean arterial pressure in men but not in
women in the Framingham cohort, thus indicating sex-
specificity [29]. This observation is consistent with our results
showing that ADM is associated with hypertension
susceptibility only in the male Sardinian population.
NLRP6/AVR has been linked to salt-sensitive hypertension in
Dhal rats. Genetic analysis in an F2 (Dahl S × Dahl R)-
intercross rat population delineated NLRP6/AVR as a
candidate gene underlying a chromosome 1 BP-m2 QTL [12].
BP-m2 has shown sex-specificity since it has been detected
only in the F2 male population and not in females [12].
Additionally, functional androgen and estrogen response
elements have been delineated within the NLRP6/AVR 5′-
regulatory region that may contribute to the sex-specific effects
of NLRP6/AVR [30]. Moreover, an NLRP6/AVR structural
variant has been identified in Dahl S rats exhibiting sodium-
induced dysfunction affecting ligand binding and hormone-
dependent signal transduction [17]. This supports a
pathogenetic role of NLRP6/AVR in salt-sensitive hypertension
in Dhal rats. The role of NLRP6/AVR in blood pressure
regulation is further supported by the recent findings showing
that NLRP6/AVR deficiency affects urinary concentrating ability
and lowers blood pressure in mice [31]. Our data are consistent
with the hypothesis that NLRP6/AVR contributes to
hypertension susceptibility in humans.
In conclusion, our results revealed an association between
NLRP6/AVR and ADM loci and hypertension susceptibility in a
northern Sardinian population, primarily affecting male
essential hypertension. Specific ADM and NLRP6/AVR variants




This study was performed in strict accordance with the
principles expressed in the Declaration of Helsinki. The
protocol was approved by the local ethics committee of Local
Health Unit-University of Sassari Medical School. Written
informed consent was obtained and all clinical investigation
was conducted according to the principles expressed in the
Declaration of Helsinki.
Study population
The study cohort comprised 712 subjects, with 433 patients
with essential hypertension and 279 normotensive controls
enrolled at the Hypertension Center of the University of Sassari
Medical School. All subjects were white, unrelated, born in
different domains of North Sardinia previously ascertained to
have a high degree of genetic homogeneity [20,21],
ascertained to be Sardinian for at least 6 generations, and
resided in Sardinia. Hypertensive patients with BP > 160/95
Table 4. Single-point association analysis of SNPs in NLRP6/AVR and ADM with hypertension.
Gene (chr) SNP Position Pa OR (95% c.i.) Pb OR (95% c.i.) Pc OR (95% c.i.)
NLRP6/AVR (11) rs7948797 269,856 0.056 0.73 (0.57-0.94) 0.029 0.63 (0.45-0.88) 0.845 0.86 (0.60-1.24)
 rs7937440 272,274 0.032 0.76 (0.60-0.95) 0.100 0.73 (0.53-1.00) 0.585 0.79 (0.57-1.09)
 rs11246048 278,039 0.254 1.17 (0.92-1.48) 0.180 1.29 (0.92-1.81) 0.694 1.07 (0.77-1.49)
 rs4758635 283,928 0.191 0.86 (0.68-1.08) 0.150 0.79 (0.57-1.09) 0.838 0.92 (0.67-1.28)
ADM (11) rs4399321 10,323,478 0.104 1.23 (0.96-1.58) 0.142 1.31 (0.91-1.87) 0.410 1.16 (0.81-1.66)
 rs4444073 10,331,664 0.006 1.44 (1.13-1.84) 0.013 1.62 (1.14-2.29) 0.286 1.29 (0.92-1.81)
NLRP6, NLR family, pyrin domain containing 6; AVR, angiotensin-vasopressin receptor; ADM, adrenomedullin; Pa, P in males + females; Pb, P in males; Pc, P in females.
OR, odds ratio; c.i., confidence interval. Association analysis was performed with the HelixTree Genetic Analysis Software using Basic Allelic Tests: D vs d as genetic model.
P, Chi-Squared FDR (Chi-squared P adjusted for multiple comparisons with False Discovery Rate procedure). Significant results (P < 0.05) are shown in boldface type.
doi: 10.1371/journal.pone.0077562.t004
AVR and ADM loci in Essential Hypertension
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mmHg (n = 433), no secondary hypertension etiology and
absence of major comorbid conditions were considered in the
study. Older patients were included only if they were diagnosed
as hypertensive well before 55 years of age. BP measurements
were obtained with patients not taking any medications. Family
history of hypertension was investigated, and a complete
pedigree was defined. To exclude erroneous control subjects
with late-onset hypertension, normotensive controls (n = 279)
were limited to those older than 60 years of age who had not
been previously diagnosed or treated as hypertensive, had no
family history of hypertension and cardiovascular or
cerebrovascular disease, and had BP values < 135/85 on at
least 4 occasions.
Identification of tag SNPs in NLRP6/AVR and ADM
transcription units
To identify tag SNPs within the NLRP6/AVR and ADM
transcription units we genotyped 300 random samples from our
Sardinian sample with 13 NLRP6/AVR (rs7113424,
rs10902117, rs17655663, rs7948797, rs7396066, rs7937440,
rs7102570, rs10794306, rs11246048, rs4758627, rs4758635,
rs3817637, rs741737) and 8 ADM (rs73420933, rs4641466,
rs4399321, rs3814700, rs5002, rs4698, rs4444073,
rs7944706) SNPs and tagged them by using the Carlson
Method which is based on the R2 LD statistic as implemented
by HelixTree Genetic Analysis software. We used the following
parameters for tagging markers: 1) Minor Allele Frequency
Threshold = 0.1. 2) Linkage Disequilibrium (R2) Threshold =
0.8. After Carlson SNP-tagging analysis we selected the
following SNPs for association analysis (shown in Table 2):
rs7948797, rs7937440, rs11246048, rs4758635 for
NLRP6/AVR and rs4399321, rs4444073 for ADM.
Genotyping
Genotyping of microsatellite markers was performed as
described previously using 20 ng of DNA [11,14]. Alleles were
identified using 6% non-denaturing polyacrylamide gel
electrophoresis (1/2× Tris-Borate-EDTA, 750 V for 14 h). Gels
were exposed to autoradiograms for genotype readings. SNP
genotyping was carried out by the Molecular Genetics Core
Facility at the Boston University School of Medicine on a Life
Technologies 7900 Real-Time PCR System (Foster City, CA,
USA). Chromosomal position of microsatellite markers and
single nucleotide polymorphisms (SNPs) were based on the
“NCBI build 37.1-Map”. SNP assays (TaqMan assays) were
procured from Life Technologies. The genotyping
completeness rate was 87%.
Statistical analysis
Analysis of microsatellite allele frequencies between cases
and controls was performed using χ2 analysis (Sigma Plot 11.0)
for D11S1318 2x9 χ2 analysis (9 alleles), D11S1338 2×3 χ2
analysis (3 alleles), D11S1323 2×4 χ2 analysis (4 alleles),
D11S1346 2×5 χ2 analysis (5 alleles), D11S1315 2×5 χ2
analysis (5 alleles), and D11S1310 2×3 χ2 analysis (3 alleles).
Bonferroni adjustment was applied to nominal P values for
multiple testing corrections. For SNPs, single point association
analysis comparing cases and control subjects was conducted
using the HelixTreeTM SNP & Variation Suite genetic analysis
software (version 6.4.3, Golden Helix Inc., Bozeman, MT,
USA). A basic allelic test (D vs d) was implemented using a
Chi-squared test as statistical method, obtaining as well odds
ratios with corresponding confidence limits. Missing genotypes
were not included (imputed) in the association analysis. The
false discovery rate was utilized for multiple testing corrections.
A chi-squared test using our cohort with α = 0.005 predicts
statistically significant detection of at least 0.1 in allele
frequency differences between groups of 433 hypertensives
and 279 normotensive subjects with a Power > 0.8.
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